BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2011

Dec 23, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2011-12-22

Reporting Person: Wood Mark (VP, Human Resources)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-12-22	Common Stock	M	84	$17.86	Acquired	20718	Direct
2011-12-22	Common Stock	M	937	$14.39	Acquired	21655	Direct
2011-12-22	Common Stock	M	833	$21.51	Acquired	22488	Direct
2011-12-22	Common Stock	S	1854	$33.7904	Disposed	20634	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-12-22	Stock Option (right to bu) Common Stock	$17.86	M	84	Disposed	2018-12-16	Common Stock (84)	Direct
2011-12-22	Stock Option (right to buy) Common Stock	$14.39	M	937	Disposed	2019-05-11	Common Stock (937)	Direct
2011-12-22	Stock Option (right to buy) Common Stock	$21.51	M	833	Disposed	2020-05-11	Common Stock (833)	Direct

Footnotes

F1: Transaction made pursuant to a Rule 10b5-1 Trading plan executed on August 20, 2011.

F2: Original option grant vests 6/48th on June 17, 2009 and 1/48th each on the 17th of each month thereafter.

F3: Original option grant vests 6/48th on November 12, 2009 and 1/48th each on the 12th of each month thereafter.

F4: Original option grant vests 6/48th on November 12, 2010 and 1/48th each on the 12th of each month thereafter.